Does probenecid cause a clinically meaningful change in exposure to bempedoic acid?

No, steady-state probenecid increased bempedoic acid exposure (AUC) 1.7-fold and its active metabolite exposure 1.9-fold when given with bempedoic acid 180 mg, but these increases are not clinically meaningful and do not affect dosing recommendations.